University Of Minnesota Task Force Seeks Greater Transparency In Faculty Conflicts Of Interest With Pharmaceutical Companies
Main Category: Pharma Industry / Biotech IndustryAlso Included In: Public Health; Primary Care / General Practice
Article Date: 03 Oct 2008 - 5:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
A task force that examined conflicts of interest at the University of Minnesota Medical School has recommended that the university expand its disclosure policy regarding relationships between the school's faculty and the drug industry, the AP/Fargo Forum reports. The task force in an unreleased report suggested the school disclose all financial ties between faculty and the drug industry, ban gifts from medical companies, and establish a Web site that would report all conflicts of interest. The task force also recommended new limits on gifts to its physicians from drugmakers. In addition, the task force recommended that physicians disclose all relationships with pharmaceutical companies before prescribing drugs to patients. The recommendations, which the task force will forward to Dean Deborah Powell, are based on about one year of study.
Task force Co-Chair Leo Furcht said, "We think there's no place in medical education and the delivery of care for gifts to physicians." Drugmakers paid the university and its medical faculty nearly $1.5 million between 2002 and 2004, according to Public Citizen. Earlier this year, the American Medical Student Association gave the medical school a "D" grade for its current conflict-of-interest policies in part because of a guideline that allows some financial relationships with drugmakers without review from a school committee (AP/Fargo Forum, 10/1).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.
© 2008 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our pharma industry / biotech industry section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/124068.php>
APA
http://www.medicalnewstoday.com/releases/124068.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



